The Leo & Anne Albert Charitable Trust

When Anne Albert passed away from the combined effects of bladder cancer and Alzheimer’s disease-dementia, her husband Leo wanted to set up a trust as a way of helping people with the significant wealth Anne had accumulated. Leo and Anne Albert’s long-time attorney and friend, Gene Pranzo (Attorney and President of the Leo and Anne Albert Trust), knew just how to do that from his previous endeavors. Thus, Leo asked Gene to base the Albert Charitable Trust on the approaches Gene had developed previously for the Dorothy R. Havermeyer Foundation (

Gene then began to utilize Albert Trust funds, as directed by Leo, to support the science-medicine, patients and caregivers of the illnesses that afflicted Leo and Anne Albert. The work of the Leo and Anne Albert Trust now has provided help to thousands with scientific and humanistic support to cancer and dementia patients (e.g., Bladder Cancer Care and Research;, Alzheimer’s Community Care’s Care and Service Centers; bon-cutting-photos).

More recently (2013), Gene Pranzo wanted to expand Albert Charitable Trust financial support to cognitive impairment that results from cerebrovascular disease (i.e., vascular cognitive impairment-dementia; VCID).

To do this, Gene worked through the American Heart Association (AHA) and connected with Frank Barone (Professor of Neurology and Physiology & Pharmacology at SUNY Downstate Medical Center in Brooklyn, NY). Frank, a recent recipient of an AHA “Grant-In-Aid” to study VCID in 2013, and Gene discussed a plan to conduct small VCID workshops (i.e., utilizing a “small scientific workshop model” approach that was so successful for the Albert Trust previously) to better understand critical brain changes and their mechanisms in producing VCID.

Quick Contact


We believe that our newly formed Albert Institute will fill a gap in white matter science, providing white matter and cognition communications, including annual updates from workshops and the literature and interconnecting with other Albert Trust scientific endeavors in cognition and dementia.